HPV vaccine for boys in Tanzania
Part of Infections clinical trials.
This trial studies whether giving one dose of the HPV vaccine to boys, in addition to vaccinating girls, helps protect more people from HPV-related cancers. Boys aged 14-18 who live in certain communities in Tanzania may be able to take part.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a boy between 14 and 18 years old at the time of vaccination.
- You must live in a community that is part of the study.
- You must be generally healthy, though having HIV is allowed.
- You must not have had the HPV vaccine before.
- You must be willing to avoid other vaccines for 14 days after getting the study vaccine.
- You must be able to attend a clinic for the injection and any follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at giving the HPV vaccine (Gardasil 9) to women while they go through Sweden’s routine HPV screening. It helps researchers understand how vaccine use alongside screening affects HPV infection and cervical cancer prevention.
This trial tests an 11-type HPV vaccine to prevent infection from multiple HPV strains. If you enroll, you’ll receive scheduled vaccine doses and have health and gynecologic check-ins to see how well the vaccine works and is tolerated.
This trial tests a way to give HPV vaccines along with routine childhood immunizations in Ghana. It aims to protect against HPV, a virus that can cause cervical cancer, by making it easier to get the vaccine.
This study looks at how HPV vaccines are given to girls in Ethiopia, aiming to improve access and uptake. It involves interviews and surveys with girls and their caregivers.
This study combines HPV vaccination with other health services for young people in Ivory Coast. It aims to protect adolescents against HPV, which can cause cancer, while also checking their overall health and well-being.
This study tests whether a single dose of the HPV vaccine (Gardasil 9) can reduce HPV infection and transmission in women. It might help prevent cervical cancer and other HPV-related conditions.
Hear when a new HPV Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.